header
European Commission Calls
category MSCA
Call Identifier: HORIZON-MSCA-2024-SE-01-01 MSCA Staff Exchanges 2024 (HORIZON-MSCA-2024-SE-01-01)

MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
•Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
•The organisations constituting the partnership contribute directly to the implementation of a joint R&I project by seconding and/or hosting eligible staff members.
•Such a project must explore activities that can be based on previous work but should go beyond and generate or strengthen long-term collaborations. Secondments must involve physical mobility of the eligible staff members and must always take place between legal entities independent from each other.
MSCA Staff Exchanges can address three dimensions of mobility: international, inter-sectoral and interdisciplinary.

Budget: EUR 81.226.000 (for year 2024)
Deadline: 05 March 2025 (Opening date: 10 October 2024)
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

Call Identifier: HORIZON-MSCA-2025-COFUND-01-01 MSCA COFUND 2025 HORIZON-MSCA-2025-COFUND-01-01

Scope: Applicants submit proposals for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level. These programmes will be co-funded by MSCA COFUND.
Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.
A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.
A) Doctoral programmes
Doctoral programmes offer research training activities to allow doctoral candidates to develop and broaden their skills and competences. The training activities should be based on the EU Principles on Innovative Doctoral Training.
Substantial training modules, including digital ones, addressing key transferable skills and competences common to all fields, fostering good scientific conduct such as research integrity, and fostering the culture of Open Science, innovation and entrepreneurship will be supported.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Collaboration with a wider set of associated partners, including from the non-academic sector, will be positively taken into account during the evaluation. These organisations may provide hosting or secondment opportunities or training modules in research or transferable skills.
Particular attention is paid to the quality of supervision and mentoring arrangements as well as career guidance.
B) Postdoctoral Programmes
Postdoctoral Programmes fund individual advanced research training and career development fellowships for postdoctoral researchers. The programmes should offer training to develop key transferable skills and competences common to all fields, foster good scientific conduct such as research integrity, foster innovation and entrepreneurship and promote and (where appropriate) reward Open Science practices (open access to publications and to other research outputs including data, FAIR data management, societal engagement and citizen science, etc.).
Postdoctoral Programmes should have regular selection rounds following fixed deadlines or regular cut-off dates, allowing fair competition between researchers.
Applicants are encouraged to include elements of cross-sectoral mobility and interdisciplinarity into their programmes. Researchers will be able to freely choose a research topic and the appropriate organisation to host them, fitting their individual needs.

Budget: 101.820.280 EUR (Postdoctoral programme);
101.820.280 EUR (Doctoral programme)

Deadline: 24 June 2025
Who can apply:
1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other eligibility conditions: described in the MSCA part of the Work Programme.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

 


category Innovative Europe
Innovative Europe Call Identifier: EIC Pathfinder EIC Pathfinder Open

Scope: to develop the scientific basis to underpin breakthrough technologies. Support for the earliest stages of scientific, technological or deep-tech research and development. Pathfinder projects aim to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realising innovative technological solutions. Support for projects in any field of science, technology or application without predefined thematic priorities.
You should apply if you are looking for support from EIC Pathfinder Open to realise an ambitious vision for radically new technology, with potential to create new markets and/or to provide solutions for global challenges. EIC Pathfinder Open supports early stage development of such future technologies (e.g., various activities at low Technology Readiness Levels from 1 to 4), based on high-risk/high-gain science to wards-technology breakthrough research (including ‘deep-tech’). This research must provide the foundations of the technology you are envisioning.

Budget: The total indicative budget for this call is EUR 142 million.
For this call, the EIC considers proposals with a requested EU contribution of up to EUR 3 million as appropriate.

Deadline: 21 May 2025
Who can apply: This call is open for collaborative research. Your proposal must be submitted by the coordinator, on behalf of a consortium including as beneficiaries, at least three legal entities, independent from each other and each established in a different country as follows:
• at least one legal entity established in a Member State; and
• at least two other independent legal entities, each established in different Member States or Associated Countries.
The legal entities may for example be universities, research organisations, SMEs, startups, industrial partners or natural persons.

Innovative Europe Call Identifier: EIC Pathfinder EIC Pathfinder Challanges

Scope: to develop the scientific basis to underpin breakthrough technologies. Support for the earliest stages of scientific, technological or deep-tech research and development. Pathfinder projects aim to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realising innovative technological solutions. Support for coherent portfolios of projects within predefined thematic areas with the aim of achieving specific objectives for each Challenge.
EIC Pathfinder Challenges 2025:
1. Biotech for Climate Resilient Crops and Plant-Based Biomanufacturing: To enhance adaptation pathways for the production of climate-resilient crops and develop alternative pathways to produce high value ingredients in plants by increasing nutrient profile of crops based on plant native and/or non-native ingredients.
2. Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer: To create interactive GenAI autonomous agents and/or a combination of them that provide clinicians with a holistic end to end perspective of patient care.
3. Towards autonomous robot collectives delivering collaborative tasks in dynamic unstructured construction environments: Enabling autonomous robot collectives to collaboratively perform complex construction tasks in dynamic, unstructured environments. Advancing robotic collaboration and electrification to revolutionize on-site building processes and enhance efficiency, safety, and sustainability.
4. Waste-to-value devices: Circular production of renewable fuels, chemicals and materials: Developing of next generation technologies that turn today’s problematic waste streams into essential building blocks of a future circular economy.
You should apply if you have a potential cutting-edge project that would contribute to the specific objectives of the respective Challenge. Specifically, your proposed project must aim to deliver by its end the expected outcomes defined in the respective Challenge. In general, the starting point of a proposal answering to a Pathfinder Challenge is early TRL (e.g., 2) to up to proof of concept or validation in the lab (e.g., TRL 3 or 4). Project results should also include top-level scientific publications, adequate formal protection of the generated intellectual property (IP) as well as an assessment of relevant aspects related to regulation, certification and standardisation.

Budget: The total indicative budget for this call is EUR 120 million which is expected to be allocated in approximately equal shares across the Challenges.
For this call, the EIC considers proposals with an EU contribution of up to EUR 4 million as appropriate. Nonetheless, this does not preclude you to request larger amounts, if duly justified or stated otherwise in the specific Challenge.

Deadline: 29 October 2025
Who can apply: Support for collaborative or individual research and innovation from consortia or from single legal entities established in a Member State or an Associated Country (unless stated otherwise in the specific Challenge chapter).
In case of a consortium your proposal must be submitted by the coordinator on behalf of the consortium. Consortia of two entities must be comprised of independent legal entities from two different Member States or Associated Countries. Consortia of three or more entities must include as beneficiaries at least three legal entities, independent from each other and each established in a different country as follows:
• at least one legal entity established in a Member State; and
• at least two other independent legal entities, each established in different Member States or Associated Countries.
The legal entities may for example be universities, research organisations, SMEs, startups, natural persons. In the case of single beneficiary projects, mid-caps and larger companies will not be permitted.

Innovative Europe Call Identifier: EIC Transiiton EIC Transition Open

Scope: EIC Transiiton funds s innovation activities that go beyond the experimental proof of principle in laboratory (applications must have completed all elements of Technology Readiness Level 3). It supports both the maturation and validation of your novel technology from the lab to the relevant application environments (by making use of prototyping, formulation, models, user testing or other validation tests) as well as explorations and development of a sustainable business plan and business model towards commercialisation into high potential markets.

Budget: The total indicative budget for this call is EUR 98 million.
For this call, the EIC considers proposals with a requested EU contribution of more than EUR 0.5 million and less than EUR 2.5 million and duration between 1 and 3 years as appropriate. Nonetheless, in exceptional cases, this does not preclude you to request larger amounts, if very well motivated and duly explained.

Deadline: 17 September 2025
Who can apply: Your proposal must build on results already achieved within an eligible project that are, at least, at experimental proof of concept (applications must have completed all elements of Technology Readiness Level 3or, ideally, technology validated in the lab level (TRL 4).
Proposals building on project results at other TRLs level are not eligible. EIC Transition is restricted to proposals based on results generated by eligible project as indiacted in the Workprogramme.
You can apply for EIC Transition either as:
• A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’) if you are a start-up, SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors in such institutions who intend to form a spin-off company). Larger companies (i.e. which do not qualify as SMEs) are not eligible to apply as a single legal entity; or
• A small consortium of two independent legal entities from two different Member States or Associated Countries, or
• A consortium of minimum three and maximum five eligible independent legal entities (‘multi-beneficiary’) following standard rules i.e. must include at least one legal entity established in a Member State and at least two other independent legal entities, each established in different Member States or Associated Countries.

European Innovation Council (EIC) Call Identifier: EIC Accelerator EIC Accelerator Open

Scope: This call is for innovations in any field of technology and innovations that cut across different scientific, technological, sectoral and application fields.
The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs that:
• have a innovative, game changing product, service or business model that could create new markets or disrupt existing ones in Europe and even worldwide,
• have the ambition and commitment to scale up,
• are looking for substantial funding, but the risks involved are too high for private investors alone to invest

Budget: EUR 384 million of the total indicative budget will be allocated to EIC Accelerator Open.
Grant component below EUR 2.5M for innovation activities (TRL 6 to 8). Investment component of EUR 0.5 up to 10 million for scaling up and other activities. Grant only and investment only component under certain conditions.
For further information consult Funding&Tender Portal and Work Programme.

Deadline: Short applications: any time (continuous)
Full applications: 12 March 2025, 1 October 2025

Who can apply: Single start-ups and SMEs (including spin-offs), individuals (intending to launch a start-up/ SME) and in some cases small mid-caps (fewer than 499 employees).

European Innovation Council (EIC) Call Identifier: EIC Accelerator EIC Accelerator Challenges

Scope: The EIC Accelerator Challenges calls are open to proposals in predefined topics that have been identified in areas where breakthrough technologies or game-changing innovations developed by start-ups or SMEs can have a major impact on EU objectives.
In 2025 support for start-ups in semiconductor technologies and quantum technologies will be pursued in particular through STEP Scale Up.
EIC Accelerator Challenges 2025:
1. Acceleration of advanced materials development and upscaling along the value chain: Scaling SMEs belonging to the whole value chain of advanced materials and addressing one or more of these four key application areas: energy, mobility, electronics, construction.
2. Biotechnology driven low emission food and feed production systems: Radically decreasing greenhouse gas emissions and the wider environmental footprint of the food production system requires further action on several fronts.
3. GenAI4EU: Creating European Champions in Generative AI: To support start-ups and SMEs committed to bringing transformative AI-driven solutions to market, to safeguard human autonomy and enhance human expertise thus providing significant added value to decision-making processes, services or industrial workflows.
4. Innovative in-space servicing, operations, robotics and technologies for resilient EU space infrastructure: To support companies developing cost-effective, scalable and resilient solutions to service and/or augment satellite capabilities, perform in-orbit refuelling, contribute to space debris reduction, and protect EU space infrastructure.
5. Breakthrough innovations for future mobility: To support cost-effective and scalable deep tech breakthroughs that will help deliver reductions in mobility-related emissions.

Budget: The total indicative budget for EIC Accelerator Challenges is EUR 250 million.
Grant component below EUR 2.5M for innovation activities (TRL 6 to 8). Investment component of EUR 0.5 up to 10 million for scaling up and other activities. Grant only and investment only component under certain conditions.
For further information consult Funding&Tender Portal and Work Programme.

Deadline: 12 March 2025
1 October 2025

Who can apply: Single start-ups and SMEs (including spin-offs), individuals (intending to launch a start-up/ SME) and in some cases small mid-caps (fewer than 499 employees).

 


category Co-funded by the European Union
Call Identifier: THCS - Transforming Health and Care Systems, JTC - Joint Translational Call 2025 "“Better care closer to home: Enhancing primary and community care” HORIZON-HLTH-2022-CARE-10-01 - European partnership on transforming health and care systems

Scope: Improve primary and community health and care systems, providing policymakers with knowledge and tools to manage transitions within the primary and community care sector. Projects funded under this call will deliver promising financial, organizational, and practice-based service innovations that promote the transformation of health and care systems and contribute to faster exchange of best practices across different countries and regions.

Budget: Total funding available is 32 270 000,00 €.

Deadline: 30 January 2025, 14:00 CET (deadline for submission of pre-proposal)
19 June 2025, 14:00 CEST (deadline for submission of full-proposals)

Who can apply: Applicants should contact their corresponding regional/national representative to enquire about eligibility with their respective funding organisations prior to applying.
Link to the call text: https://www.thcspartnership.eu/kdocs/2169112/thcs-jtc-2025-call-text-v1.1.pdf
Link to call: https://www.thcspartnership.eu/funding/jtc-2025-better-care-closer-to-home.kl

Call Identifier: ERDERA - European Rare Diseases Research Alliance ("Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”) 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

Scope: The primary objective of the call is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings. Eligible proposals may include research on:
• Development of pre-clinical therapies using cell, organoid, or animal models.
• Biomarker identification that correlates with therapeutic efficacy.
• Pre-clinical proof-of-concept studies showing pharmacological activity and safety data.
Notably, gene therapies, rare neurodegenerative diseases like Alzheimer’s, and rare cancers are excluded from this call. Projects should have a special focus on therapies that can translate into clinical applications.

Budget: Please consult the call text. Link to call text: https://erdera.org/wp-content/uploads/2024/12/ERDERA-JTC2025-Call-text-VF.pdf
Deadline: 13 February 2025, 14:00 CET (deadline for submission of pre-proposal)
9 July 2025, 14:00 CEST (deadline for submission of full-proposals)

Who can apply: Please consult the guidelines. Link to guidelines: https://erdera.org/wp-content/uploads/2024/12/ERDERA-JTC2025-Guidelines-VF.pdf

Call Identifier: ERA4Health Partnership - “Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases” (EffecTrial) EffecTrial: "Fostering Pragmatic Comparative-Effectiveness Trials in Non-communicable Diseases”

Scope: The aims of the call is to support randomised, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated Clinical Studies (IICS) which could include but would not be limited to: diagnostic, screening, prevention and treatment interventions. The interventions can be pharmacological as well as non-pharmacological procedures like nutrition and/or lifestyle interventions. These interventions shall have high public relevance only in the fields of these specific diseases or conditions:
• Cardiovascular diseases
• Metabolic disorders
• Nutrition and lifestyle-related diseases
• Non-communicable respiratory diseases

Budget: Please consult the call text. Link to call text: https://era4health.eu/calls/docs/ERA4Health_Call%20Text_EffecTrial.pdf

Deadline: 18 February 2025, 14:00 CET(deadline for submission of pre-proposal)
17 July 2025, 14:00 CEST (deadline for submission of full-proposals)

Who can apply: Please consult the guidelines. Link to guidelines: https://era4health.eu/calls/docs/ERA4Health_Guideline_for_Applicants_EffecTrial.pdf

Call Identifier: EP PerMed - European Partnership for Personalized Medicine, JTC2025 - Joint Translational call 2025 (Pre-announcement – Pharmacogenomic Strategies for Personalised Medicine (PGxPM2025) Pharmacogenomic Strategies for Personalised Medicine (PGxPM2025)

Scope: Support research projects in human health on pharmacogenomic strategies for personalised medicine approaches that address one or more of the following aspects: identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination; validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes; use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication).

Budget: Please consult the call text. Link to call text: https://www.eppermed.eu/news-events/news/ep-permed-jtc2025-pre-announcement-pharmacogenomic-strategies-for-personalised-medicine-pgxpm2025/

Deadline: 18 February 2025, 14:00 CET (deadline for submission of pre-proposal)
17 June 2025, 14:00 CEST (deadline for submission of full-proposals)

Who can apply: Please consult the call text. Link to call text: https://www.eppermed.eu/news-events/news/ep-permed-jtc2025-pre-announcement-pharmacogenomic-strategies-for-personalised-medicine-pgxpm2025/

 


category EU4Health
Call Identifier: EU4H-2024-PJ-03-1 (DP-g-24- 25) Call for proposals to support a comprehensive, prevention-oriented approach to mental health in the Union - (DP-g-24-25) EU4H-2024-PJ-03-1


Budget: Topic budget: 2.000.000 EUR.
Expected nr of grant agreements to be signed: 4
Expected duration: 36 months
Indicative project budget: 500.000 EUR

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: At least one NGO working in the field of mental health; At least one patient organisation working in the field of mental health.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks including ERNs, civil society organisations: associations, foundations, NGOs and similar entities, established networks in the field of public health.

Call Identifier: EU4H-2024-PJ-03-2– a/b/c (DP/CR-g-24-29) Call for proposals on health promotion and prevention of noncommunicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke-and aerosol-free environments

Scope: The activities could cover the following areas of action:
a) promotion of good mental health and prevention of mental health problems through mental health literacy and awareness-raising, knowledge-sharing and exchange programmes for health professionals, creation of and participation in networks of institutions, patients and health professionals, identification and sharing of best and promising practices and approaches and implementable research results;
b) support for the design of integrated and coherent health policy approaches to key mental health challenges for children, such as those posed by the digital world (e.g., misinformation, cyberbullying, body shaming, aggressive marketing, undue access to inappropriate content, addiction and concentration deficit);
c) support for the design of comprehensive and coherent policy approaches and toolkits to address key social, environmental, commercial and behavioural factors influencing the mental health of citizens, including children and young people and their mental resilience;
d) better and earlier detection and intervention of mental health problems through development, piloting and implementation of approaches and tools for early detection and intervention in various settings e.g., schools, workplaces, prisons and community settings;
e) improved access to evidence-based, innovative, promising and community-level approaches and interventions in the management of mental health challenges;
f) improved quality of life through appropriate and patient-centred follow-up care with a focus on rights and breaking through stigma and discrimination.

Budget: Topic budget EU4H-2024-PJ-03-2 – a: 750.000 EUR; EU4H-2024-PJ-03-2 – b: 833.333 EUR; EU4H-2024-PJ-03-2 – c: 500.000 EUR.
Expected nr of grant agreements to be signed: EU4H-2024-PJ-03-2 – a: 2; EU4H-2024-PJ-03-2 – b: 3; EU4H-2024-PJ-03-2 – c: 2.
Expected duration: 36 months

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.

Call Identifier: EU4H-2024-PJ-03-3 (CR-g-24-42) Call for Proposals on radiation safety and quality of computed tomography imaging of children and young adults - (CR-g-24-42) EU4H-2024-PJ-03-3

Scope: The activities carried out in this action should include the following:
a) review of referral guidelines for imaging, clinical guidelines, and clinical decision support systems in use in Member States for justification of radiological imaging in children, adolescents and young adults and recommendations for improvement of these guidelines to the relevant actors;
b) review of the equipment base and the access to dedicated paediatric imaging in Member States and recommendations for improvement of the equipment base to the relevant actors;
c) development of guidance, protocols and tools for optimisation of paediatric CT exams, for the CT devices and the clinical indications that are the most used in Europe;
d) the organisation of information and dissemination campaigns concerning recommendations, guidance, protocols and tools for justification and optimisation of paediatric imaging among the concerned hospitals and medical centres in all Member States;
e) development of education and training curricula, material, and tools on radiation protection of paediatric patients, for the applicable professional groups;
f) the organisation of a training of radiologists, radiographers, medical physicists, and radiology nurses in practical approaches to radiation protection of paediatric patients;
g) the organisation of information campaigns about the benefits, risks and radiation safety of imaging in paediatric, adolescent and young adult patients, targeted at parents and young adults.

Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 48 months

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: Academia and education establishments, research institutes, hospitals, expert networks, civil society organisations, associations, foundations, NGOs, enterprises (incl. social enterprises and not for profit) in the field of public health, private entities (for profit/not for profit), international organisations, Member States’ authorities.

Call Identifier: EU4H-2024-PJ-03-4 (CR-g-24-99) Call for proposals on Personalised Cancer Medicine - (CR-g-24-99) EU4H-2024-PJ-03-4

Scope: Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:
a) the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);
b) the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;
c) patients and caregivers consultations, and other actions that can benefit citizens directly;
d) preparation and roll out of innovative practices;
e) support capacity building actions such as training and twinning, health communication or health literacy.

Budget: Topic budget: 3.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.

Call Identifier: EU4H-2024-PJ-03-5 (CR-g-24-96) Call for proposals to support the establishment of new networks of expertise on cancer and cancer conditions - (CR-g-24-96) EU4H-2024-PJ-03-5

Scope: Activities will complement the joint action on new networks of expertise to be launched under the EU4Health work programme 2023 (CR-g-23-40.1-2), and include:
a) implementing targeted projects involving patient organisations, civil societies, non-government organisations complementing the Member States’ efforts in the design, planning and implementation of the networks;
b) the establishment of best practices, the production of public health, treatment guidelines, or other actions that can benefit patients;
c) the preparation and roll out of innovative practices (pilot tests), and support actions such as training and twinning, health communication or health literacy.
Support activities could include:
a) practical support (to help patients better understand the impact of cancer and treatment; managing the side effects of cancer and cancer treatment);
b) emotional support (regular consultations in support groups and workshops, aimed at supporting and helping patients to manage the difficult psychological and emotional impact of cancer);
c) education and information (practical information on diet in cancer, oncology workshops for healthcare professionals and support personnel, tailored to specific types of cancer and their symptoms).

Budget: Topic budget: 1.000.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 months

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.

Call Identifier: EU4H-2024-PJ-03-6 (DI-g-24-76) Call for proposals on advancing the adoption of artificial intelligence in health (DI-g-24-76) EU4H-2024-PJ-03-6

Scope: The activities for this action should include the following actions:
a) the setting up and running of one or more communities of experts and relevant stakeholders for delving into the potentials and challenges concerning AI deployment in clinical practice. In this respect, this should provide proposals on how to ensure sustainability of this expert community beyond the end of the project;
b) the analysis and identification of the factors that lead to the successful and less successful deployment of AI in healthcare as well as challenges and obstacles, in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects. Two particular areas of interest that should be included are AI in cancer and AI in remote areas and medical deserts;
c) the preparation of good deployment practices for AI in healthcare, recommendations and guidelines tailored to the needs of the specific users/environments in healthcare to accelerate the safe and effective deployment of AI in clinical practice in collaboration with the expert community or communities mentioned under point a) and taking into account existing studies and projects.
d) the design, development, and execution of pilots to test and evaluate in diverse real-life environments the expert community(ies)’s developed good deployment practices, guidelines and recommendations. As part of the pilots, to analyse how clinical practice is changing with the incorporation of AI systems.
e) the development of user friendly interactive digital tool(s) that allows for the collection and communication of AI solutions successfully deployed in different clinical settings.
f) the organisation of workshops and communication activities addressed to different stakeholders.
g) the provision of a summary of lessons learned and recommendations for potential policy measures that would contribute to accelerating the safe and effective deployment of AI in clinical practice.

Budget: Topic budget: 4.500.000 EUR.
Expected nr of grant agreements to be signed: 1
Expected duration: 36 and 48 months

Deadline: 22 January 2025
Who can apply: Consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Additional specific consortium composition criteria: see call document.
Other eligibility conditions: see call document.
header
Other Calls
header
National Calls
Italia domani - PNRR
Bandi e avvisi dei soggetti attuatori Call Identifier: https://www.italiadomani.gov.it/content/sogei-ng/it/it/opportunita/bandi-soggetti-attuatori.html Bandi e avvisi dei soggetti attuatori

In questa sezione è possibile consultare bandi e avvisi pubblici per cogliere le opportunità del PNRR volte a migliorare la vita pubblica di tutto il Paese.

Budget: Consultare il sito del bando
Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.

 


Finanziamento IKIGAI - FMPS
Finanziamento di progetti individuali Call Identifier: https://ikigai.fondazionemps.it/il-bando/ BANDO IKIGAI 2022 – 2024


Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.

Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.

Deadline: Consultare il sito del bando
Who can apply: Consultare il sito del bando.

 

 

 

 

 

   


Innovation Acta S.r.l. | Via delle Province, 1 - 53100 Siena - Italy | VAT number: 13201341008

© 2020 Innovation Acta - All rights reserved

PRIVACY

Innovation Acta S.r.l.
VAT number: 13201341008

+39 0577 1652729
  +39 366 3746125

  info@innovationacta.eu
  acta_srl@pec.it

Registered office and operational headquarter:
Via delle Province, 1 - 53100 Siena - Italy


Branch office:
Via D.A. Azuni, 9 - 00196 Roma - Italy